FDA

Trang chủ » Phi Fda » FDA

Có thể bạn quan tâm

loader imageClose Menu Philippine Standard Time Philippine Standard Time --:--:-- -- Philippine Standard Time Philippine Standard Time --:--:-- -- Menu Search May 2025 BannerJanuary 2023 BannerMicrosoftTeams-image (5)MORESlideSlideSlide 1Learn MoreIECMORE previous arrownext arrow

Services

Image Click Redirect - Container 1 Logo Click to start

For Applications Involving Cosmetics and Household / Urban Hazardous Substances and Toys and Child Care Articles and Establishments

Image Click Redirect - Container 2 Logo Click to start

For Applications Involving Pre-Packaged Food Products and Establishments

Image Click Redirect - Container 3 Logo Click to start

For Applications Involving Medical and Radiation Emitting Devices and Establishments

Image Click Redirect - Container 4 Logo Click to start

For Applications Involving Drug Products and Establishments

Reporting and Verification

eSumbong e-Sumbong Form (formerly eReport) E-Recall Pharmacovigilance Verification Portal Market Surveillance

Announcements

𝐅𝐃𝐀 𝐖𝐀𝐑𝐍𝐒 𝐀𝐆𝐀𝐈𝐍𝐒𝐓 𝐂𝐎𝐔𝐍𝐓𝐄𝐑𝐅𝐄𝐈𝐓 𝐀𝐍𝐃 𝐔𝐍𝐑𝐄𝐆𝐈𝐒𝐓𝐄𝐑𝐄𝐃 𝐌𝐄𝐃𝐈𝐂𝐈𝐍𝐄𝐒
  • General Announcements

𝐅𝐃𝐀 𝐖𝐀𝐑𝐍𝐒 𝐀𝐆𝐀𝐈𝐍𝐒𝐓 𝐂𝐎𝐔𝐍𝐓𝐄𝐑𝐅𝐄𝐈𝐓 𝐀𝐍𝐃 𝐔𝐍𝐑𝐄𝐆𝐈𝐒𝐓𝐄𝐑𝐄𝐃 𝐌𝐄𝐃𝐈𝐂𝐈𝐍𝐄𝐒

16 February 2026 During a live interview on DZXL News 558 on 11 February 2026, the Food and Drug Administration (FDA), through its... Read More
  • General Announcements
13 February 2026 Nagbabala ang Food and Drug Administration (FDA) sa publiko laban sa mga kumakalat sa merkado na food supplement at herbal... Read More FDA HIGHLIGHTS THE FDA VERIFICATION PORTAL
  • General Announcements

FDA HIGHLIGHTS THE FDA VERIFICATION PORTAL

13 February 2026 The Food and Drug Administration (FDA), through its spokesperson Atty. Khay Ann Magundayao-Borlado, participated in an interview aired on PTV... Read More FDA OUTLINES NATIONWIDE COORDINATED VERIFICATION VISITS
  • General Announcements

FDA OUTLINES NATIONWIDE COORDINATED VERIFICATION VISITS

13 February 2026 The Food and Drug Administration (FDA) Philippines, through its spokesperson Atty. Khay Ann Magundayao-Borlado, participated in an interview on 10... Read More Announcement || DISSEMINATION OF THE CONSOLIDATED AMENDMENTS TO THE ASEAN COSMETIC DIRECTIVE (ACD) AS ADOPTED DURING THE 40TH to 42ND ASEAN COSMETIC COMMITTEE (ACC) MEETING AND THEIR RELATED MEETINGS
  • Cosmetic Announcements

Announcement || DISSEMINATION OF THE CONSOLIDATED AMENDMENTS TO THE ASEAN COSMETIC DIRECTIVE (ACD) AS ADOPTED DURING THE 40TH to 42ND ASEAN COSMETIC COMMITTEE (ACC) MEETING AND THEIR RELATED MEETINGS

12 February 2026 In the interest of service, and in order to provide timely dissemination of the updates and amendments to the ASEAN... Read More URGENT FDA OPERATION UNCOVERS RABIES VACCINE HANDLING AND DISTRIBUTION VIOLATIONS
  • General Announcements

URGENT FDA OPERATION UNCOVERS RABIES VACCINE HANDLING AND DISTRIBUTION VIOLATIONS

12 February 2026 The Food and Drug Administration (FDA), through the Field Regulatory Operations Office – North Luzon Cluster, conducted an urgent enforcement... Read More FDA SUPPORTS ACCESSIBLE HEALTHCARE AND PRODUCT SAFETY IN PARAÑAQUE’S LAB FOR ALL INITIATIVE
  • General Announcements

FDA SUPPORTS ACCESSIBLE HEALTHCARE AND PRODUCT SAFETY IN PARAÑAQUE’S LAB FOR ALL INITIATIVE

10 February 2026 Parañaque City - On 10 February 2026, the Food and Drug Administration (FDA) participated in the Lab for All (LFA)... Read More FDA CAUTIONS CONSUMERS AGAINST BUYING UNREGISTERED HEALTH PRODUCTS
  • General Announcements

FDA CAUTIONS CONSUMERS AGAINST BUYING UNREGISTERED HEALTH PRODUCTS

10 February 2026 The Food and Drug Administration (FDA) reiterated its call for the public to exercise caution when purchasing health products, whether... Read More Licensing Seminar for Medical Device Establishments (LS-MD)
  • Academy Training Schedule

Licensing Seminar for Medical Device Establishments (LS-MD)

6 February 2026 A licensing seminar from the FDA Center for Device Regulation, Radiation Health, and Research stakeholders which aims to provide information... Read More Webinar on the Technical Requirements and Regulatory Guidelines for Toys and Childcare Article Products (TR-TCCAP)
  • Academy Training Schedule

Webinar on the Technical Requirements and Regulatory Guidelines for Toys and Childcare Article Products (TR-TCCAP)

6 February 2026 This webinar will provide detailed discussions on the technical requirements and procedure for the issuance of Certificate of Product Notification... Read More View More

Latest Advisories

FDA ADVISORY NO.2026-0362 || Food and Drug Administration Philippine Nuclear Research Institute (FDA-PNRI) Joint Order Establishing The PhilATOM Transition Committee
  • General Advisories

FDA ADVISORY NO.2026-0362 || Food and Drug Administration Philippine Nuclear Research Institute (FDA-PNRI) Joint Order Establishing The PhilATOM Transition Committee

16 February 2026 The Food and Drug Administration (FDA) and the Philippine Nuclear Research Institute (PNRI) are currently engaged in a strategic and... Read More FDA Advisory No.2026-0358 || Pilot Implementation of e-Services for Registration Applications of Processed Food Products under Center for Food Regulation and Research (CFRR)
  • Food Advisories

FDA Advisory No.2026-0358 || Pilot Implementation of e-Services for Registration Applications of Processed Food Products under Center for Food Regulation and Research (CFRR)

12 February 2026 The Food and Drug Administration (FDA) informs all concerned stakeholders that, following the successful completion of the pilot testing phase... Read More FDA Advisory No.2026-0115-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot “San Sierra Century Balm Natural Base Ointment 10 Grams”
  • Drugs Advisories

FDA Advisory No.2026-0115-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot “San Sierra Century Balm Natural Base Ointment 10 Grams”

12 February 2026 Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot: 1. San... Read More FDA Advisory No.2026-0115 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “San Sierra Century Balm Natural Base Ointment 10 Grams”
  • Drugs Advisories

FDA Advisory No.2026-0115 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “San Sierra Century Balm Natural Base Ointment 10 Grams”

12 February 2026 The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug product:... Read More FDA Advisory No.2026-0094 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “P.ORGANIC GINKGO BILOBA FOOD SUPPLEMENT DIETARY SUPPLEMENT”
  • Food Advisories

FDA Advisory No.2026-0094 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “P.ORGANIC GINKGO BILOBA FOOD SUPPLEMENT DIETARY SUPPLEMENT”

12 February 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the... Read More FDA ADVISORY NO.2026-0089 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “AVOCADO ORIGINAL SOAP”
  • Cosmetic Advisories

FDA ADVISORY NO.2026-0089 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “AVOCADO ORIGINAL SOAP”

12 February 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the... Read More FDA ADVISORY NO.2026-0087 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “GLUTA WHITE & FIRM FACIAL CREAM”
  • Cosmetic Advisories

FDA ADVISORY NO.2026-0087 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “GLUTA WHITE & FIRM FACIAL CREAM”

12 February 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the... Read More FDA ADVISORY NO.2026-0086 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “LUCA BOSSI PERFUME BROS POUR HOMME”
  • Cosmetic Advisories

FDA ADVISORY NO.2026-0086 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “LUCA BOSSI PERFUME BROS POUR HOMME”

12 February 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the... Read More FDA ADVISORY NO.2026-0085 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “NIACINAMIDE ORIGINAL TAWAS SOAP”Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “NIACINAMIDE ORIGINAL TAWAS SOAP”
  • Cosmetic Advisories

FDA ADVISORY NO.2026-0085 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “NIACINAMIDE ORIGINAL TAWAS SOAP”Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “NIACINAMIDE ORIGINAL TAWAS SOAP”

12 February 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the... Read More FDA Advisory No.2026-0079 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “BLOOM AURA ALPHA SURGE WASH PENIS ENLARGING SOAP”
  • Cosmetic Advisories

FDA Advisory No.2026-0079 || Public Health Warning Against the Purchase and Use of the Unauthorized Cosmetic Product “BLOOM AURA ALPHA SURGE WASH PENIS ENLARGING SOAP”

12 February 2026 The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the... Read More View More

Latest Issuances

  • FDA Circular

FDA Circular No.2025-007 || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)

16 December 2025 FDA Circular No.2025-007 || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)
  • FDA Circular

FDA Circular No.2025-006 || IMPLEMENTATION OF ONLINE USER ACCOUNT REGISTRATION AND RENEWAL FOR FDA EPORTAL, EPORTAL2, AND RRDPORTAL WITHIN THE FDA ESERVICES PLATFORM

16 December 2025 FDA Circular No.2025-006 || IMPLEMENTATION OF ONLINE USER ACCOUNT REGISTRATION AND RENEWAL FOR FDA EPORTAL, EPORTAL2, AND RRDPORTAL WITHIN THE FDA ESERVICES PLATFORM
  • Administrative Order
  • Drugs Advisories

Administrative Order No. 2025-0024 || Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use

26 November 2025 Administrative Order No. 2025-0024 || Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use
  • FDA Circular

FDA Circular No.2025-005 || Delisting of Purchase Booklet from the Checklist of Requirements to Avail of the 20% Senior Citizen Discount on the Purchase of Medicines and Medical Devices in Accordance with the Department of Health Administrative Order No. 2024-0017 Entitled, “Purchase Booklets No Longer Required for the 20% Senior Citizens’ Discount on Medicines, in Compliance with Republic Act No. 9994, Otherwise Known as “The Expanded Senior Citizens Act of 2010””

4 September 2025 FDA Circular No.2025-005 || Delisting of Purchase Booklet from the Checklist of Requirements to Avail of the 20% Senior Citizen Discount on the Purchase of Medicines and Medical Devices in Accordance with the Department of Health Administrative Order No. 2024-0017 Entitled, “Purchase Booklets No Longer Required for the 20% Senior Citizens’ Discount on Medicines, in Compliance with Republic Act No. 9994, Otherwise Known as “The Expanded Senior Citizens Act of 2010””
  • FDA Circular

FDA Circular No.2025-004 || Adoption of Codex Standard for Follow-Up Formula for Older Infants and Product/Drink for Young Children (CXS 156-1987) as Technical Regulation

14 July 2025 FDA Circular No.2025-004 || Adoption of Codex Standard for Follow-Up Formula for Older Infants and Product/Drink for Young Children (CXS 156-1987) as Technical Regulation
  • FDA Circular

FDA Circular No.2025-003 || Adoption of Codex Guidelines for Ready-To-Use Therapeutic Foods (RUTF) (CXG 95-2022) as Technical Regulation

3 July 2025 FDA Circular No.2025-003 || Adoption of Codex Guidelines for Ready-To-Use Therapeutic Foods (RUTF) (CXG 95-2022) as Technical Regulation
  • FDA Circular

DEPARTMENT CIRCULAR NO.2025-0240 || Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”

11 June 2025 DEPARTMENT CIRCULAR NO.2025-0240 || Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
  • FDA Circular

FDA Circular No.2025-002 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings

18 March 2025 FDA Circular No.2025-002 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings
  • FDA Circular

FDA Circular No.2025-001 || Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults under Processed Food Product, Repealing the Level Set for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

7 January 2025 FDA Circular No.2025-001 || Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults under Processed Food Product, Repealing the Level Set for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”
  • Administrative Order

Administrative Order No. 2024-0016 || Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration

3 January 2025 Administrative Order No. 2024-0016 || Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration View More

Draft for Comments

  • Draft for Comments

Draft for Comments || Guidelines on the Classification of Deficiencies Observed during the Conduct of Inspection According to Risk, and the Procedure of Compliance of Food Business Operators to the Observed Deficiencies

16 February 2026 All comments can be sent at [email protected]. Deadline of submission of comments shall be by March 17, 2026. I. BACKGROUND... Read More Draft for Comments || Guidelines on the Classification of Deficiencies Observed during the Conduct of Inspection According to Risk, and the Procedure of Compliance of Food Business Operators to the Observed Deficiencies
  • Draft for Comments

Draft for Comments || Guidelines on the Use of Electronic Services (e-Services) System for the Registration of Processed Food Products Repealing, FDA Circular No. 2020-033 “Procedure for the Use of the Modified Electronic Registration System for Raw Materials and Prepackaged Processed Food Products”

16 February 2026 This draft policy on the FDA e-Services System is an initial working draft and remains subject to ongoing internal review,... Read More Draft for Comments || Guidelines on the Use of Electronic Services (e-Services) System for the Registration of Processed Food Products Repealing, FDA Circular No. 2020-033 “Procedure for the Use of the Modified Electronic Registration System for Raw Materials and Prepackaged Processed Food Products”
  • Draft for Comments

Draft for Comments || Adoption of Codex General Standard for Fruit Juices and Nectars (CXS 247-2005) as Technical Regulation

11 February 2026 All comments shall be sent to [email protected]. The deadline for submission of comments is on 03 March 2026. I. RATIONALE In... Read More Draft for Comments || Adoption of Codex General Standard for Fruit Juices and Nectars (CXS 247-2005) as Technical Regulation
  • Draft for Comments

Draft for Comments || General Guidelines on the Regulatory Compliance of Food Contact Articles (FCA) Used for Prepackaged Processed Food Products

3 February 2026 All comments shall be sent to [email protected]. The deadline for submission of comments is on 04 March 2026. I. RATIONALE... Read More Draft for Comments || General Guidelines on the Regulatory Compliance of Food Contact Articles (FCA) Used for Prepackaged Processed Food Products
  • Draft for Comments

Draft for Comments || Philippine National Standard Mature Coconut Water – Specification

20 January 2026 All comments shall be sent to [email protected]. The deadline for submission of comments is on 09 February 2026. Read More Draft for Comments || Philippine National Standard Mature Coconut Water – Specification
  • Draft for Comments

Draft for Comments || Prescribing the Guidelines for the Application of Certificate of Good Manufacturing Practice (GMP) Compliance for Local and Foreign Pharmaceutical Manufacturers

12 January 2026 All comments shall be sent to [email protected] The deadline for submission of comments is on 18 February 2026. I. RATIONALE... Read More Draft for Comments || Prescribing the Guidelines for the Application of Certificate of Good Manufacturing Practice (GMP) Compliance for Local and Foreign Pharmaceutical Manufacturers
  • Draft for Comments

Draft for Comments || Guidelines on the Use of Acceptable Nutrition and Health Claims in the Labeling, Advertisement, Sponsorships, Promotions, and Other Marketing Activities of Prepackaged Processed Food Products

17 December 2025 All comments shall be sent to [email protected]. The deadline for submission of comments is on 15 January 2026. I. BACKGROUND The... Read More Draft for Comments || Guidelines on the Use of Acceptable Nutrition and Health Claims in the Labeling, Advertisement, Sponsorships, Promotions, and Other Marketing Activities of Prepackaged Processed Food Products
  • Draft for Comments

Draft for Comments || Operational Procedures on the Application for Sales Promotion Permit with the Food and Drug Administration

11 December 2025 Deadline for commenting: 12 January 2026 All comments shall be submitted in MSWord and pdf file formats to [email protected] using... Read More Draft for Comments || Operational Procedures on the Application for Sales Promotion Permit with the Food and Drug Administration
  • Device Announcements
  • Draft for Comments
  • General Announcements

Announcement || DRAFT FOR COMMENTS: Guidelines for the Recognition of Radiation Protection Officers (RPO) and Qualified Experts (QE) for Ionizing Radiation Facilities under FDA

11 December 2025 The Center for Device Regulation, Radiation Health, and Research (CDRRHR) hereby circulates the latest draft of the proposed FDA Circular... Read More Announcement || DRAFT FOR COMMENTS: Guidelines for the Recognition of Radiation Protection Officers (RPO) and Qualified Experts (QE) for Ionizing Radiation Facilities under FDA
  • Draft for Comments

Draft for Comments || Amendment to Administrative Order No. 2024-0016 entitled “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”

26 November 2025 The Policy and Planning Office (PPO) is hereby circulating the updated draft of the proposed Administrative Order, provisionally entitled “Amendment... Read More Draft for Comments || Amendment to Administrative Order No. 2024-0016 entitled “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration” View More

Bids and Awards

  • ITB and RFQ

ITB No. 2026-0007-ICMTD || Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet Service and Telephone Subscription for the Food and Drug Administration (FDA) – One Trium Tower for One (1) Year

6 February 2026 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet... Read More ITB No. 2026-0007-ICMTD || Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet Service and Telephone Subscription for the Food and Drug Administration (FDA) – One Trium Tower for One (1) Year
  • ITB and RFQ

SVP(A)-2026-0005-FDA-Academy || Procurement for the supply and delivery of the various Collaterals and Training Materials for the Promotion of FDA Academy Trainings/Seminars

5 February 2026 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the supply and delivery of the various Collaterals and Training Materials for... Read More SVP(A)-2026-0005-FDA-Academy || Procurement for the supply and delivery of the various Collaterals and Training Materials for the Promotion of FDA Academy Trainings/Seminars
  • ITB and RFQ

NP-SVP-2025-019-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)

22 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of... Read More NP-SVP-2025-019-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)
  • ITB and RFQ

NP-SVP(A)-2025-0202-FDAC || Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the FDAC, Cashier, and Records Releasing Office on the 8th Floor of Kingston Excell Building

18 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the... Read More NP-SVP(A)-2025-0202-FDAC || Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the FDAC, Cashier, and Records Releasing Office on the 8th Floor of Kingston Excell Building
  • ITB and RFQ

NP-SVP(A)-2025-0184-ATQAL REPOST || Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps

12 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps... Read More NP-SVP(A)-2025-0184-ATQAL REPOST || Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps
  • ITB and RFQ

NP-SVP(A)-2025-0193-ATQAL REPOST || Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2

12 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2 Read More NP-SVP(A)-2025-0193-ATQAL REPOST || Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2
  • ITB and RFQ

NP-SVP-2025-013-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)

12 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of... Read More NP-SVP-2025-013-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)
  • ITB and RFQ

NP-SVP-2025-018-MIN || Procurement for the Supply and Delivery of Office Supplies for various Offices of FDA (Per lot)

10 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Office Supplies for various Offices of FDA... Read More NP-SVP-2025-018-MIN || Procurement for the Supply and Delivery of Office Supplies for various Offices of FDA (Per lot)
  • ITB and RFQ

NP-SVP-2025-016-MEC || Supply and Delivery of Information and Communication Technology (ICT) Equipment for Mindanao East Cluster

10 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply and Delivery of Information and Communication Technology (ICT) Equipment for Mindanao East Cluster... Read More NP-SVP-2025-016-MEC || Supply and Delivery of Information and Communication Technology (ICT) Equipment for Mindanao East Cluster
  • ITB and RFQ

NP-SVP-2025-015-MIN || Procurement of HVAC Maintenance Service Provider for the various offices of FDA

10 December 2025 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of HVAC Maintenance Service Provider for the various offices of FDA Read More NP-SVP-2025-015-MIN || Procurement of HVAC Maintenance Service Provider for the various offices of FDA View More

Featured Event

Play Previous Next View More

Featured Activity

  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒

By Administrator 3 / 4 September 2025 As part of its continuing advocacy to reach out to communities, the Food and Drug Administration (FDA), in partnership... Read More Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒
  • Featured Activities

Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖

By Administrator 3 / 4 September 2025 Baguio City – On 26 August 2025, the Food and Drug Administration (FDA) actively participated in the Department of... Read More Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑

By Administrator 3 / 4 September 2025 Candon City, Ilocos Sur – The Food and Drug Administration (FDA) took part in the Lab For All caravan... Read More Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄

By Administrator 3 / 4 September 2025 Manila City – On 4 August 2025, FDA Director General Paolo S. Teston welcomed Dr. Jinho Shin and Mr.... Read More Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘

By Administrator 3 / 4 September 2025 San Juan City – Last 26 August 2025, the Food and Drug Administration (FDA) participated in the Lab For... Read More Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓

By Administrator 3 / 4 September 2025 Makati City — The Food and Drug Administration (FDA), through its Director General Paolo S. Teston, reaffirmed its commitment... Read More Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒

By Administrator 3 / 4 September 2025 Quezon City – On 30 July 2025, the Food and Drug Administration (FDA), headed by Director General Paolo S.... Read More Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒

By Administrator 3 / 4 September 2025 Alabang, Muntinlupa – As part of its continuing efforts to strengthen regulatory capacity and laboratory competency, the Food and... Read More Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍

By Administrator 3 / 4 September 2025 Pasay City – In celebration of National MSME Week 2025, with the theme “Asenso Negosyo, Angat Kabuhayan: Bagong Pilipinas,”... Read More Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍
  • Featured Activities

Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐘 𝐄𝐍𝐆𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐀𝐓 𝐓𝐇𝐄 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐌𝐀𝐋𝐀𝐁𝐎𝐍 𝐂𝐀𝐑𝐀𝐕𝐀𝐍

By Administrator 3 / 4 September 2025 Malabon City – On Tuesday, 25 July 2025, the Food and Drug Administration (FDA) participated in the Lab For... Read More Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐘 𝐄𝐍𝐆𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐀𝐓 𝐓𝐇𝐄 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐌𝐀𝐋𝐀𝐁𝐎𝐍 𝐂𝐀𝐑𝐀𝐕𝐀𝐍 View More

Featured Video

Play Play Play Play Play Play Play Play Play Play Play Previous Next

Press Statements

  • Press Statement

𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐉𝐀𝐏𝐀𝐍 𝐏𝐌𝐃𝐀 𝐈𝐍𝐒𝐓𝐈𝐓𝐔𝐓𝐈𝐎𝐍𝐀𝐋𝐈𝐙𝐄 𝐒𝐂𝐈𝐄𝐍𝐂𝐄-𝐁𝐀𝐒𝐄𝐃 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐑𝐄𝐋𝐈𝐀𝐍𝐂𝐄 𝐅𝐑𝐀𝐌𝐄𝐖𝐎𝐑𝐊 𝐔𝐍𝐃𝐄𝐑 𝐁𝐈𝐋𝐀𝐓𝐄𝐑𝐀𝐋 𝐂𝐎𝐎𝐏𝐄𝐑𝐀𝐓𝐈𝐎𝐍 𝐌𝐄𝐂𝐇𝐀𝐍𝐈𝐒𝐌

13 February 2026 Manila, Philippines — On 12 February 2026, the Food and Drug Administration Philippines (FDA) and the Pharmaceuticals and Medical Devices... Read More 𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐉𝐀𝐏𝐀𝐍 𝐏𝐌𝐃𝐀 𝐈𝐍𝐒𝐓𝐈𝐓𝐔𝐓𝐈𝐎𝐍𝐀𝐋𝐈𝐙𝐄 𝐒𝐂𝐈𝐄𝐍𝐂𝐄-𝐁𝐀𝐒𝐄𝐃 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐑𝐄𝐋𝐈𝐀𝐍𝐂𝐄 𝐅𝐑𝐀𝐌𝐄𝐖𝐎𝐑𝐊 𝐔𝐍𝐃𝐄𝐑 𝐁𝐈𝐋𝐀𝐓𝐄𝐑𝐀𝐋 𝐂𝐎𝐎𝐏𝐄𝐑𝐀𝐓𝐈𝐎𝐍 𝐌𝐄𝐂𝐇𝐀𝐍𝐈𝐒𝐌
  • Press Statement

PRESS RELEASE || FDA CONDUCTS COORDINATED VERIFICATION VISITS NATIONWIDE TO PROTECT CONSUMERS

6 February 2026 Taguig City - Today, 6 February 2026, the Food and Drug Administration (FDA) conducted coordinated compliance verification visits to selected... Read More
  • Press Statement

FDA Press Statement || FDA STATEMENT ON THE VOLUNTARY RECALL OF SELECT INFANT FORMULA PRODUCTS

12 January 2026 The Food and Drug Administration (FDA) informs the public that it is actively overseeing and validating the voluntary recall initiated... Read More FDA Press Statement || FDA STATEMENT ON THE VOLUNTARY RECALL OF SELECT INFANT FORMULA PRODUCTS
  • Press Statement

FDA Press Statement || FDA Reaffirms Commitment to Strengthening Transparency and Efficiency

3 June 2025 Alabang, Muntinlupa City — The Food and Drug Administration (FDA), following the initiative of Director General Paolo S. Teston,... Read More FDA Press Statement || FDA Reaffirms Commitment to Strengthening Transparency and Efficiency
  • Press Statement

FDA Press Statement || FDA Actively Participates During the 2025 USP Convention

3 June 2025 Washington D.C., U.S.A. — To strengthen its global commitment to pharmaceutical excellence and public health, the Food and Drug... Read More FDA Press Statement || FDA Actively Participates During the 2025 USP Convention
  • Press Statement

FDA Press Statement || FDA Director General Urges Suspension of New Regulatory Fees

29 May 2025 Quezon City — The Food and Drug Administration (FDA) urges the Department of Health to approve the immediate suspension... Read More FDA Press Statement || FDA Director General Urges Suspension of New Regulatory Fees
  • Press Statement

FDA Press Statement || DOH USEC. ATTY. PAOLO S. TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCY’S SERVICE TO THE NATION

15 May 2025 Alabang, Muntinlupa City — May 13, 2025 The Food and Drug Administration (FDA) of the Philippines welcomed its... Read More FDA Press Statement || DOH USEC. ATTY. PAOLO S. TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCY’S SERVICE TO THE NATION
  • Press Statement

FDA Press Statement || FDA Addresses Regulatory Concerns and Promotes Streamlined Processes in PAPPI Seminar

23 April 2025 The Food and Drug Administration (FDA) actively participated in the 1st Quarter Seminar of the Philippine Association of Pharmacists in... Read More FDA Press Statement || FDA Addresses Regulatory Concerns and Promotes Streamlined Processes in PAPPI Seminar
  • Press Statement

FDA Press Statement || FDA PARTNERS WITH BICOL SUCs TO BOOST MSME GROWTH

23 April 2025 The Food and Drug Administration (FDA) has actively collaborated with State Universities and Colleges (SUCs) in the Bicol Region... Read More FDA Press Statement || FDA PARTNERS WITH BICOL SUCs TO BOOST MSME GROWTH
  • Press Statement

FDA Press Statement || FDA Joins LAB for ALL Program in Teresa, Rizal

23 April 2025 The Food and Drug Administration (FDA), under the leadership of Director General Dr. Samuel A. Zacate, reaffirmed its continued... Read More FDA Press Statement || FDA Joins LAB for ALL Program in Teresa, Rizal View More
Quick Links
Contact Information
    • Department of Health (DOH)
    • Department of Information and Communications Technology (DICT)
    • Department of Science and Technology (DOST)
    • Anti-Red Tape Authority (ARTA)

 

Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City[email protected]  Landline: (02)-8257-1957(02)-8286-6087(02)-8273-0481(02)-8800-4392(02)-8273-3756(02)-8659-7330

Copyright ⓒ 2026. All Rights Reserved.

Copyright ⓒ 2026. All Rights Reserved.

Shares

Từ khóa » Phi Fda